apomorphine has been researched along with benserazide in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (69.49) | 18.7374 |
| 1990's | 8 (13.56) | 18.2507 |
| 2000's | 3 (5.08) | 29.6817 |
| 2010's | 6 (10.17) | 24.3611 |
| 2020's | 1 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Rinne, UK | 1 |
| Crossman, AR; Sambrook, MA; Slater, P | 1 |
| Bailey, RC; Bracs, PU; Jackson, DM | 1 |
| Antkiewicz, L; Grabowska, M; Michaluk, J | 1 |
| Baldessarini, RJ; Griffith, FF | 1 |
| Darwish, SA; Furman, BL | 1 |
| Jahodová, J; Pribyl, T; Schreiber, V | 1 |
| Ljungberg, T; Ungerstedt, U | 1 |
| Dinnendahl, V; Gumulka, SW; Peters, HD; Schönhöfer, PS | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Pohto, P | 1 |
| Halvorsen, KA; Martensen-Larsen, O | 1 |
| Dadkar, VN; Dahanukar, SA; Sheth, UK | 1 |
| Uemura, H | 1 |
| Gessa, GL; Mereu, G; Paglietti, E; Quarantotti, BP | 1 |
| Ernst, AM | 1 |
| Bartolini, A; Mantovani, P; Pepeu, G | 1 |
| Gräf, HJ; Horowski, R | 1 |
| Kuschinsky, K | 1 |
| Przewlocki, R | 1 |
| Chen, S | 1 |
| Jenkins, JR; Pearce, JM | 1 |
| Burke, RE; Reches, A | 1 |
| Carboni, S; Gessa, GL; Pani, L; Portas, CM; Rossetti, ZL | 1 |
| Berendsen, HH; Broekkamp, CL | 1 |
| Aizenstein, ML; de-Lucia, R; Scavone, C; Steinschreiber, S | 1 |
| Farel, PB; McClellan, AD | 1 |
| Bartholini, G; Keller, HH; Pletscher, A | 1 |
| Roth, RH; Walters, JR | 1 |
| Gressier, H; Malecot, E; Poignant, JC | 1 |
| Papeschi, R | 1 |
| Bläsig, J; Herz, A; Papeschi, R | 1 |
| Aghajanian, GK; Bunney, BS; Roth, RH | 1 |
| Cashin, CH; Sutton, S | 1 |
| Ayhan, IH; Randrup, A | 1 |
| Baran, L; Grabowska, M; Maj, J; Sowińska, H | 1 |
| Fratta, W; Gessa, GL; Tagliamonte, A | 1 |
| Dandiya, PC; Patni, SK | 1 |
| Jackson, DM; Miller, LP; Walters, JR | 1 |
| Casey, DE; Gerlach, J | 1 |
| Achilli, G; Algeri, S; Cimino, M; Lipartiti, M; Perego, C; Ponzio, F; Vantini, G | 1 |
| Christie, MJ; Gregory, P; Jackson, DM; Jenkins, OF; Malor, R | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Bailey, R; Crisp, E; Jackson, DM; Jenkins, O | 1 |
| Baring, MD; Eng, N; Walters, JR | 1 |
| Albani, C; Bächli, E | 1 |
| Boldry, RC; Chase, TN; Engber, TM; Kask, AM; Papa, SM | 1 |
| Cammarota, A; Leiguarda, R; Merello, M; Pikielny, R | 1 |
| Honey, CR; Shen, H | 1 |
| Chesselet, MF; Fleming, SM; Hutson, CB; Levine, MS; Masliah, E; Rockenstein, E; Salcedo, J | 1 |
| Aguilar, E; Bartoszyk, GD; Marin, C; Obeso, JA; Rodríguez-Oroz, MC | 1 |
| Ballion, B; Chetrit, J; Frenois, F; Gonon, F; Murer, MG; Zold, CL | 1 |
| Ascenzi, P; Bolli, A; di Masi, A; Fanali, G; Fasano, M; Lopiano, L; Rampoldi, V | 1 |
| Kunselman, AR; Lieu, CA; Manyam, BV; Subramanian, T; Venkiteswaran, K | 1 |
| Geng, XC; Yin, LL; Zhu, XZ | 1 |
| Grandas, FJ; Sesar-Ignacio, Á | 1 |
| Chen, C; Fan, Q; Huang, J; Pan, X; Wei, H | 1 |
| Chavez-Blanco, A; Correa-Basurto, J; Dominguez-Gomez, G; Duenas-Gonzalez, A; Garcia-Martinez, E; Gonzalez-Fierro, A; Romo-Perez, A; Taja-Chayeb, L | 1 |
3 review(s) available for apomorphine and benserazide
| Article | Year |
|---|---|
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
Compulsive gnawing.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Benserazide; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Iproniazid; Levodopa; Male; Methyldopa; Methyltyrosines; Rats; Serotonin; Structure-Activity Relationship; Time Factors | 1976 |
[Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Topics: Aftercare; Ambulatory Care; Antiparkinson Agents; Apomorphine; Benserazide; Carbidopa; Caregivers; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infusions, Subcutaneous; Levodopa; Parkinson Disease; Patient Education as Topic; Patient Selection; Retrospective Studies | 2012 |
1 trial(s) available for apomorphine and benserazide
| Article | Year |
|---|---|
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in Parkinson's disease patients: a double-blind single-dose study.
Topics: Administration, Oral; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease | 1997 |
55 other study(ies) available for apomorphine and benserazide
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway.
Topics: Amphetamine; Animals; Apomorphine; Benserazide; Callitrichinae; Disease Models, Animal; Drug Therapy, Combination; Haloperidol; Haplorhini; Hydroxydopamines; Hypothalamus; Levodopa; Locus Coeruleus; Male; Torticollis | 1979 |
Long-term L-dopa pretreatment of mice: central receptor subsensitivity or supersensitivity?
Topics: Animals; Apomorphine; Benserazide; Dextroamphetamine; Drug Interactions; Levodopa; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Adrenergic; Time Factors | 1979 |
Pharmacologic effects of apomorphine in rats with altered level of brain serotonin.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Benserazide; Body Temperature; Brain Chemistry; Female; Fenclonine; Humans; Motor Activity; p-Chloroamphetamine; Pargyline; Rats; Serotonin; Spectrometry, Fluorescence; Stereotyped Behavior | 1975 |
Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior; Behavior, Animal; Benserazide; Dose-Response Relationship, Drug; Drug Synergism; Fenclonine; Humans; Male; Pargyline; Rats; Stereotyped Behavior; Time Factors | 1976 |
Effects of levodopa and dopamine of plasma glucose concentration in mice.
Topics: Animals; Apomorphine; Benserazide; Blood Glucose; Carbidopa; Cyproheptadine; Dopamine; Fatty Acids, Nonesterified; Fenclonine; Haloperidol; Insulin; Levodopa; Liver Glycogen; Male; Methysergide; Mice; Nialamide; Pargyline; Pimozide; Time Factors | 1977 |
Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
Topics: Animals; Apomorphine; Benserazide; Cyproheptadine; Estrogens; Haloperidol; Levodopa; Pituitary Gland, Anterior; Pyridoxine; Rats; Thyroxine-Binding Proteins | 1978 |
Automatic registration of behaviour related to dopamine and noradrenaline transmission.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine; Dose-Response Relationship, Drug; Isotonic Solutions; Levodopa; Male; Methods; Motor Activity; Norepinephrine; Phenoxybenzamine; Rats; Synaptic Transmission | 1976 |
Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Benserazide; Brain; Cerebellum; Cyclic AMP; Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoquinolines; Levodopa; Male; Mice; Nucleotides, Cyclic; Stereotyped Behavior | 1976 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Experimental aggression and bruxism in rats.
Topics: Aggression; Animals; Apomorphine; Benserazide; Bruxism; Ditiocarb; Electroshock; Humans; Iproniazid; Levodopa; Male; Rats; Stereotyped Behavior | 1979 |
Apomorphine revived: fortified, prolonged, and improved therapeutical effect.
Topics: Aged; Alcoholism; Apomorphine; Benserazide; Capsules; Drug Combinations; History, 18th Century; History, 20th Century; Humans; Levodopa; Male; Substance-Related Disorders; Tablets | 1978 |
Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
Topics: Animals; Apomorphine; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Clonidine; Dopamine; Drug Interactions; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Pentylenetetrazole; Phenoxybenzamine; Propranolol; Receptors, Dopamine; Reserpine; Seizures; Tetrabenazine | 1979 |
[Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benserazide; Dopamine; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Methyltyrosines; Pimozide; Stereotyped Behavior | 1979 |
Apomorphine and L-DOPA lower ejaculation threshold in the male rat.
Topics: Animals; Apomorphine; Benserazide; Brain; Carboxy-Lyases; Ejaculation; Levodopa; Male; Pimozide; Rats; Receptors, Dopamine; Serotonin; Sexual Behavior, Animal | 1978 |
Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Topics: Acetylcholine; Animals; Apomorphine; Benserazide; Bromocriptine; Cats; Cerebral Cortex; Dopamine; Female; Haloperidol; Levodopa; Male; Parasympathetic Nervous System; Rats; Time Factors | 1977 |
Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
Topics: Animals; Apomorphine; Benserazide; Clonidine; Dextroamphetamine; Dopamine; Female; Haloperidol; Hypophysectomy; Levodopa; Male; Methyltyrosines; Piribedil; Pituitary Gland; Prolactin; Rats; Reserpine; Sulpiride; Transplantation, Homologous | 1976 |
Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
Topics: Animals; Apomorphine; Benserazide; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Levodopa; Male; Morphine; Probenecid; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome | 1975 |
The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (DMAA) on ponto-geniculo-occipital (PGO) waves in cats.
Topics: Amantadine; Animals; Apomorphine; Benserazide; Cats; Dopamine; Electroencephalography; Geniculate Bodies; Memantine; Occipital Lobe; Serotonin | 1975 |
[Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamines; Animals; Apomorphine; Benserazide; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca mulatta; Parkinson Disease, Secondary | 1992 |
Paradoxical akinetic response to apomorphine in parkinsonism.
Topics: Apomorphine; Benserazide; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Preserved striatal tyrosine hydroxylase activity, assessed in vivo, following neonatal hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzazepines; Brain Ischemia; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hydrazines; Hypoxia; Kinetics; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Spiperone; Tyrosine 3-Monooxygenase | 1991 |
Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release?
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Corpus Striatum; Dextroamphetamine; Dialysis; Dopamine; Extracellular Space; Kainic Acid; Levodopa; Male; Pargyline; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Synapses; Synaptic Transmission | 1990 |
Drug-induced penile erections in rats: indications of serotonin1B receptor mediation.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Benserazide; Haloperidol; Male; Nialamide; Penile Erection; Piperidines; Propranolol; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tranquilizing Agents | 1987 |
Differential changes in dopaminergic receptor sensitivity induced by agonist drugs.
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Catalepsy; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1985 |
Pharmacological activation of locomotor patterns in larval and adult frog spinal cords.
Topics: 2-Aminoadipic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Aspartic Acid; Benserazide; Clonidine; In Vitro Techniques; Larva; Levodopa; Locomotion; N-Methylaspartate; Nialamide; Rana catesbeiana; Rana pipiens; Spinal Cord | 1985 |
Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression.
Topics: Acetylcholine; Animals; Apomorphine; Arecoline; Atropine; Basal Ganglia; Benserazide; Corpus Striatum; Cortical Spreading Depression; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Male; Nicotine; Oxotremorine; Parasympathetic Nervous System; Pargyline; Potassium Chloride; Quinolizines; Rats; Receptors, Drug; Time Factors | 1973 |
Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
Topics: Animals; Apomorphine; Benserazide; Brain; Brain Chemistry; Dihydroxyphenylalanine; Dioxoles; Dopamine; Fluorometry; Hydroxybutyrates; Lactones; Male; Neurons; Phenylacetates; Piperazines; Pyrimidines; Rats; Synaptic Transmission; Time Factors; Tritium; Tyrosine; Tyrosine 3-Monooxygenase | 1974 |
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl | 1974 |
An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
Topics: 5-Hydroxytryptophan; Aggression; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Benserazide; Biogenic Amines; Body Temperature; Catecholamines; Chlorisondamine; Clonidine; Depression, Chemical; Dihydroxyphenylalanine; Fenclonine; Haloperidol; Humans; Lysergic Acid Diethylamide; Male; Methysergide; Motor Activity; Pargyline; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Receptors, Adrenergic; Stereotyped Behavior; Yohimbine | 1974 |
Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Benserazide; Brain Chemistry; Catecholamines; Cocaine; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Eye Movements; Humans; Levallorphan; Male; Methyltyrosines; Morphine; Morphine Dependence; Motor Activity; Nasal Mucosa; Norepinephrine; Piperazines; Rats; Serotonin; Substance Withdrawal Syndrome | 1974 |
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.
Topics: Action Potentials; Animals; Apomorphine; Benserazide; Brain Chemistry; Chloral Hydrate; Depression, Chemical; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Male; Mesencephalon; Methyltyrosines; Neurons; Rats; Substantia Nigra | 1973 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
Inhibitory effects of amphetamine, L-DOPA and apomorphine on morphine-induced behavioural excitation of rats.
Topics: Animals; Apomorphine; Behavior, Animal; Benserazide; Dextroamphetamine; Dihydroxyphenylalanine; Grooming; Morphine; Motor Activity; Rats; Stimulation, Chemical; Time Factors | 1973 |
Effect of clonidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid brain levels.
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Carboxy-Lyases; Clonidine; Dihydroxyphenylalanine; Drug Interactions; Hydroxyindoleacetic Acid; Male; Mice; Organ Size; Rats; Serotonin; Time Factors | 1973 |
Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats.
Topics: Animals; Apomorphine; Benserazide; Copulation; Dihydroxyphenylalanine; Drug Combinations; Ejaculation; Haloperidol; Male; Sexual Behavior, Animal | 1974 |
Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benserazide; Chlorpromazine; Clonidine; Dihydroxyphenylalanine; Dopamine; Humans; Methyltyrosines; Norepinephrine; Phenoxybenzamine; Pimozide; Rats; Receptors, Drug; Reserpine; Thiocarbamates; Time Factors | 1974 |
Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Basal Ganglia; Benserazide; Corpus Striatum; Dextroamphetamine; Dopamine; Evoked Potentials; Homovanillic Acid; Levodopa; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1982 |
Dopamine agonists in clinical research for new tardive dyskinesia treatments.
Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Benserazide; Carbidopa; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Synaptic Transmission | 1983 |
In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
Topics: Animals; Apomorphine; Benserazide; Binding Sites; Cell Membrane; Corpus Striatum; Dopamine; Hydrazines; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Tetrahydronaphthalenes; Tyrosine 3-Monooxygenase | 1984 |
Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
Topics: Animals; Apomorphine; Benserazide; Humans; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1983 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
Topics: Animals; Apomorphine; Benserazide; Body Temperature Regulation; Brain; Clonidine; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Male; Mice; Motor Activity; Norepinephrine; Substance Withdrawal Syndrome | 1981 |
Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
Topics: Animals; Apomorphine; Benserazide; Corpus Striatum; Dominance, Cerebral; Dopamine; Dose-Response Relationship, Drug; Evoked Potentials; Kainic Acid; Male; Neural Pathways; Neurons; Pyrrolidines; Rats; Receptors, Dopamine; Substantia Nigra | 1980 |
[Akinetic crisis in Parkinson disease].
Topics: Aged; Aged, 80 and over; Apomorphine; Benserazide; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1994 |
Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benserazide; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Injections; Injections, Intraventricular; Levodopa; Male; Movement; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Rotation; Stereotyped Behavior; Substantia Nigra | 1995 |
Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Apomorphine; Benserazide; Corpus Striatum; Dopamine Agents; Dopamine Agonists; Injections, Intraperitoneal; Levodopa; Male; Motor Activity; Oxidopamine; Quinolinic Acid; Rats; Rats, Wistar; Substantia Nigra; Thalamic Nuclei | 1998 |
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.
Topics: alpha-Synuclein; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benserazide; Brain; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Genetic Predisposition to Disease; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Parkinson Disease; Stereotypic Movement Disorder | 2006 |
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.
Topics: Animals; Apomorphine; Benserazide; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Immunohistochemistry; Levodopa; Male; Microinjections; Organic Chemicals; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Rotation; Serotonin Receptor Agonists; Stereotyped Behavior; Subthalamic Nucleus; Sympathectomy, Chemical; Sympatholytics | 2009 |
D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Levodopa; Male; Neurons; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2009 |
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.
Topics: Allosteric Regulation; Antiparkinson Agents; Apomorphine; Benserazide; Heme; Humans; Protein Binding; Serum Albumin; Thermodynamics; Warfarin | 2010 |
A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Forelimb; Mucuna; Oxidopamine; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Rotation; Time Factors; Tyrosine 3-Monooxygenase; Vibrissae | 2010 |
The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Benserazide; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RGS Proteins | 2011 |
Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Topics: Animals; Apomorphine; Benserazide; Combined Modality Therapy; Drug Combinations; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Hyperbaric Oxygenation; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2015 |
BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.
Topics: Apomorphine; Benserazide; Drug Combinations; Humans; Neoplasms; Pantoprazole; Simvastatin; Trimetazidine | 2022 |